Theralase Technologies Inc. (TSXV: TLT)
0.260
+0.005 (1.96%)
Feb 5, 2025, 2:38 PM EST
Theralase Technologies Revenue
Theralase Technologies had revenue of 346.58K CAD in the quarter ending September 30, 2024, with 23.51% growth. This brings the company's revenue in the last twelve months to 986.60K, down -4.42% year-over-year. In the year 2023, Theralase Technologies had annual revenue of 1.07M, down -6.00%.
Revenue (ttm)
986.60K
Revenue Growth
-4.42%
P/S Ratio
61.29
Revenue / Employee
49.33K
Employees
20
Market Cap
64.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | 964.05K | -770.02K | -44.41% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.51B |
Curaleaf Holdings | 1.83B |
WELL Health Technologies | 957.69M |
dentalcorp Holdings | 1.51B |
Trulieve Cannabis | 1.58B |
Sienna Senior Living | 867.55M |
Cronos Group | 150.26M |
Extendicare | 1.42B |
Theralase Technologies News
- 9 days ago - Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting - Accesswire
- 2 months ago - Theralase(R) Launches Three New Clinical Study Sites in USA - Accesswire
- 2 months ago - Theralase(R) Launches New Clinical Study Site in Canada - Accesswire
- 2 months ago - Theralase Technologies Inc (TLTFF) Q3 2024 Earnings Call Highlights: Strong Clinical Data and ... - GuruFocus
- 2 months ago - Theralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Theralase(R) Release's 3Q2024 Financial Statements - Accesswire
- 2 months ago - Theralase(R) Closes Non-Brokered Private Placement - Accesswire
- 3 months ago - Theralase(R) Extends Warrants - Accesswire